SCHEMBL6793323

SCHEMBL6793323

Cc1ccc2c(c1)C(c1ccccc1)c1cc(C)ccc1O2

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.76
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 1/20 0.45
ALDH2 P05091 1/20 0.45
CYP19A1 P11511 2/20 0.42
SIRT2 Q8IXJ6 2/20 0.40
MAOB P27338 3/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
CHEK1 O14757 1/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29753886 1.00 GAA (0.76) GAAKMT2AALDH1A1ALDH2CYP19A1
SCHEMBL24402162 0.84 GAA (0.56) GAAKMT2AALDH1A1ALDH2CYP19A1
SCHEMBL29562284 0.80 GAA (0.52) GAAKMT2AALDH1A1MAOBMEN1
SCHEMBL6802025 0.80 GAA (0.51) GAAKMT2AALDH1A1MAOBMEN1
SCHEMBL5030661 0.78 ALDH1A1 (0.56) GAAKMT2AALDH1A1CYP19A1MAOB
SCHEMBL7058082 0.77 FFAR4 (0.49) GAAKMT2ACYP19A1MAOBMEN1
SCHEMBL40368 0.76 CYP2C9 (0.55) GAAKMT2AALDH1A1MAOBMEN1
SCHEMBL22068817 0.74 GAA (0.49) GAAKMT2AALDH1A1CYP19A1MAOB
SCHEMBL17238264 0.74 ALDH1A1 (0.51) GAAKMT2AALDH1A1MEN1
SCHEMBL17358724 0.74 SIRT2 (0.62) GAASIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs ISIS PHARMACEUTICALS, INC. 2004-08-05 US claimed
CN-114867733-A Ligand-2' -modified nucleic acids, synthesis thereof and intermediate compounds thereof 迪克纳制药公司 2022-08-05 CN disclosed
US-6815481-B2 FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-09 US disclosed
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs ISIS PHARMACEUTICALS, INC. 2004-08-05 US disclosed
US-20020032256-A1 Polybutadiene composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs POLM, POLRMT, POLB GAA 3616/4885KMT2A 3124/4885ALDH1A1 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.